Molina Healthcare (MOH) Stock

Michael Burry's large investment in Molina Healthcare shows that the company has strong growth rates and a stock that is undervalued, trading at 12 times its expected earnings and under 7 times its expected EBITDA. While Molina Healthcare has experienced significant growth in revenue and earnings per share, it is dealing with issues like a drop in Medicaid membership and high Medical Care Ratios. The company is focusing on both natural growth and acquisitions, supported by a solid balance sheet and good liquidity.

Molina (MOH) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.

MOH is in a strong position for growth due to increased premium income, acquisitions, and an older population in the U.S.

The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.

The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.

MOH has obtained important contracts in Michigan and Idaho to enhance services for people who qualify for both Medicare and Medicaid. This move will help the organization grow and reinforce its position in providing integrated care solutions.

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) has announced that its subsidiary, Molina Healthcare of Michigan, has received a contract from the Michigan Department of Health and Human Services (MDHHS) to offer a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP). This contract comes after the MDHHS's earlier announcement on October 9, 2024, regarding their intention to award the HIDE SNP contract, which was later canceled.

Molina (MOH) shared its earnings report 30 days ago. What can we expect for the stock moving forward?

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) has announced that it has successfully completed its previously mentioned offering of $750 million in senior notes with a 6.250% interest rate, set to mature in 2033. These notes were sold privately to individuals considered to be "qualified institutional buyers" under Rule 144A of the Securities Act of 1933, as well as to some investors outside the United States.